Thrombolysis-associated ventricular fibrillation: is it reperfusion, the drug or what?
Verheugt
F W
FW
D016255:Anistreplase / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy*; D015425:Myocardial Reperfusion / Q000009:adverse effects*; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D014693:Ventricular Fibrillation / Q000209:etiology*
D005343:Fibrinolytic Agents; D016255:Anistreplase